• $10.0M
    Market Cap
  • -79.12%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
21,796
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
17,565
N/A
0
N/A
Sales and Marketing Expense
817,554
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
-492,660
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
Total Operating Expenses
8.9M
+188.76%
3.1M
N/A
Operating Profit
-8.9M
+188.19%
-3.1M
N/A
Interest Income
N/A
N/A
5,557
N/A
Interest Expense
-1,064
0.00%
-1,064
N/A
Interest Income and Expense and Net
-1,064
-123.68%
4,493
N/A
Total Nonoperating Income and Expense
47,912
-92.65%
651,657
N/A
Income before Taxes
-8.9M
+188.19%
-3.1M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
Basic EPS and Net Income
-0.25
+212.50%
-0.08
N/A
Diluted EPS and Net Income
-0.25
+212.50%
-0.08
N/A
Basic Weighted Average Shares
34.6M
+20.31%
28.8M
N/A
Diluted Weighted Average Shares
34.6M
+20.31%
28.8M
N/A
Balance Sheet
Cash and Cash Equivalents
3.8M
+0.53%
3.8M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.8M
+0.53%
3.8M
N/A
Total Current Assets
4.8M
+3.76%
4.7M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
Total Long-Term Assets
3,783
0.00%
3,783
N/A
Total Assets
5.6M
-10.29%
6.2M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
5.3M
+3,518.11%
146,432
N/A
Total Current Liabilities
7.4M
+268.11%
2.0M
N/A
Total Long-Term Debt
4.2M
+102.48%
2.1M
N/A
Total Long-Term Liabilities
21,247
0.00%
21,247
N/A
Total Liabilities
7.4M
+264.26%
2.0M
N/A
Retained Earnings
-34.7M
+33.22%
-26.0M
N/A
Total Stockholders Equity
N/A
N/A
4.2M
N/A
Total Shares Outstanding
34.4M
+4.06%
33.1M
N/A
Cash Flow
Cash from Operating Activities
-5.4M
+38.42%
-3.9M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.4M
-28.99%
7.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-40,873.19%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
0.65
N/A
N/A
N/A
Cash Ratio
0.51
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
1.70
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow